Related Experiment Video

Updated: Jul 18, 2026

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability
07:23

Optimization of the Retinal Vein Occlusion Mouse Model to Limit Variability

Published on: August 6, 2021

The deficiencies of protein C, protein S and antithrombin III in patients with retinal vein occlusion: a Turkish

O Ates1

  • 1Department of Ophtalmology, Medical School, Ataturk University, 25240 Erzurum, Turkey. orhanates@atauni.edu.tr

Clinical and Laboratory Haematology
|November 16, 2006
PubMed

Insights

Decreased levels of protein C (PC), a key blood clotting factor, are significantly linked to the development of retinal vein occlusion (RVO). This finding highlights PC deficiency as a potential risk factor for RVO.

Area of Science:

  • Ophthalmology
  • Hematology
  • Vascular Medicine

Background:

  • Retinal vein occlusion (RVO) is a significant cause of vision loss.
  • The role of coagulation factors in RVO pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the association between decreased levels of protein C (PC), protein S, and antithrombin III and the occurrence of RVO.

Main Methods:

  • A case-control study involving 54 patients diagnosed with RVO.
  • Measurement of protein C, protein S, and antithrombin III levels in RVO patients and control subjects.
  • Statistical analysis to compare the prevalence of deficiencies between groups.

Main Results:

  • Seven out of 54 RVO patients exhibited decreased protein C (PC) levels.
  • A statistically significant difference was observed in the rate of PC deficiency between RVO patients and the control group (P < 0.05).

Conclusions:

  • Reduced levels of protein C (PC) are significantly associated with an increased risk of developing retinal vein occlusion (RVO).
  • PC deficiency may be a contributing factor in the pathogenesis of RVO.

More Related Videos

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility07:35

In Vivo Vascular Injury Readouts in Mouse Retina to Promote Reproducibility

Published on: April 21, 2022

Evisceration of Mouse Vitreous and Retina for Proteomic Analyses02:39

Evisceration of Mouse Vitreous and Retina for Proteomic Analyses

Published on: April 3, 2011

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...